Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (18,061)	$ (20,987)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	304	293
Amortization of right of use assets	838	599
Amortization of debt discount and financing costs	41	711
Stock-based compensation	2,331	3,623
Change in fair value of debt, other liabilities and derivatives	(276)	43
Series B preferred stock financing costs		2,680
Debt extinguishment		471
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	2,050	(1,867)
Accounts payable	537	(7,655)
Accrued expenses and other current liabilities	(1,285)	697
Operating lease right of use liability	(750)	(405)
Net cash used in operating activities	(14,271)	(21,797)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of machinery and equipment	(11)	(515)
Cash assumed in connection with the FLAG Merger		9
Security deposits		63
Net cash used in investing activities	(11)	(443)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from April Public Offering	5,406
Proceeds from May Inducement Offer	2,140
Proceeds from exercise of common stock warrants	2,835
Proceeds from issuance of noncontrolling interest in Nova Cell	2,000
Proceeds from issuance of convertible notes payable	3,000
Proceeds from issuance of common shares and warrants per subscription agreement	1,000
Proceeds from issuance of promissory note	600
Proceeds from exercise of pre-funded warrants	2
Proceeds from exercise of stock options		281
Proceeds from issuance of Series B preferred stock		9,590
Related party proceeds from issuance of Series B preferred stock		14,907
Proceeds from Non-Redemption and PIPE Agreements		2,763
Related party proceeds from issuance of loan payable	200
Proceeds from simple agreements for future equity (SAFE)		2,760
Proceeds from issuance of term notes payable		1,250
Related party proceeds from issuance of term notes payable		2,000
Repayment of financing lease obligations	(63)	(53)
Repayment of convertible note payable	(1,500)
Repayment of term notes payable	(300)
Payment of debt issuance costs	(9)
Payment of financing costs	(1,052)	(1,496)
Net cash provided by financing activities	14,259	32,002
Effect of exchange rate changes on cash	(29)	13
NET (DECREASE) INCREASE IN CASH AND RESTRICTED CASH	(52)	9,775
CASH AND RESTRICTED CASH BALANCE:
At beginning of the period	2,167	590
At end of the period	2,115	10,365
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	124	34
Cash paid for income taxes	10	11
SUPPLEMENTAL SCHEDULE OF NONCASH FINANCING AND INVESTING ACTIVITIES
Issuance of common stock in lieu of cash for services	311	344
Issuance of common stock in lieu of cash for SEPA commitment fee	81
Issuance of warrants for deferred compensation settlement in connection with FLAG Merger	158	705
Issuance of common stock for legal settlement	150
Issuance of convertible note for legal settlement	1,500
Financing fees included in accounts payable and accrued liabilities	289
Discount on convertible note payable	149
Deemed dividend on warrants	1,671
Issuance of common stock per conversion of convertible note	1,239
Issuance of RSUs for liability settlement	105
Issuance of common stock with term notes as interest paid in kind and other		272
Assumed liabilities from FLAG Merger		(6,808)
Assumed warrant liability from FLAG Merger		(3,389)
Issuance of common stock as a result of the FLAG Merger		56,090
Forward purchase agreement derivative asset		4,520
Deferred financing fees in connection with FLAG Merger		(2,604)
Issuance of common stock upon conversion of convertible preferred stock		9,601
Issuance of SAFE in lieu of cash for services		166
Issuance of common stock for Calidi debt settlement in connection with FLAG Merger		$ 2,234